Johnson Kevin C 4
4 · NEOGENOMICS INC · Filed Aug 27, 2019
Insider Transaction Report
Form 4
Johnson Kevin C
Director
Transactions
- Sale
Common Stock
2019-08-26$24.74/sh−11,800$291,932→ 28,285 total - Sale
Common Stock
2019-08-23$25.60/sh−41,200$1,054,720→ 40,085 total
Holdings
- 8,333
Stock Option (Right to Buy)
Exercise: $9.11From: 2017-07-28Exp: 2021-07-28→ Common Stock (8,333 underlying) - 3,017
Stock Option (Right to Buy)
Exercise: $11.60From: 2019-06-01Exp: 2023-06-01→ Common Stock (3,017 underlying) - 6,667
Stock Option (Right to Buy)
Exercise: $4.78From: 2016-05-06Exp: 2020-05-06→ Common Stock (6,667 underlying) - 10,000
Stock Option (Right to Buy)
Exercise: $7.27From: 2018-05-25Exp: 2022-05-25→ Common Stock (10,000 underlying) - 4,269
Stock Option (Right to Buy)
Exercise: $22.52From: 2020-06-06Exp: 2026-06-06→ Common Stock (4,269 underlying)
Footnotes (3)
- [F1]On May 6, 2015 Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F2]On July 28, 2016, Mr. Johnson was granted 8,333 stock options. The options vest ratably over the first three anniversary dates of the grant date.
- [F3]On May 25, 2017, Mr. Johnson was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.